Literature DB >> 11123019

A molecular insight on the association of HLA-B27 with spondyloarthropathies.

M Martí1, I Alvarez, J A López de Castro.   

Abstract

This article focuses on molecular studies concerning HLA-B27 and their relevance for its pathogenetic role in spondyloarthropathy. The peptide binding and T-cell antigen presenting properties of HLA-B27 are discussed, mainly in connection with differential subtype association to ankylosing spondylitis. Molecular studies in transgenic rodents are also considered, with an emphasis on their relevance to the various pathogenetic mechanisms. Recent studies on the putative role of HLA-B27 in bacteria-host interactions are also discussed, as they suggest another level of implication of HLA-B27 in disease whose molecular basis is obscure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11123019     DOI: 10.1007/s11926-999-0029-x

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  78 in total

1.  HLA-B27 modulates the survival of Salmonella enteritidis in transfected L cells, possibly by impaired nitric oxide production.

Authors:  M Virtala; J Kirveskari; K Granfors
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides.

Authors:  S D Khare; M J Bull; J Hanson; H S Luthra; C S David
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

3.  Invasion and persistence of Salmonella in human fibroblasts positive or negative for endogenous HLA B27.

Authors:  H I Huppertz; J Heesemann
Journal:  Ann Rheum Dis       Date:  1997-11       Impact factor: 19.103

4.  HLA-B27 subtypes positively and negatively associated with spondyloarthropathy.

Authors:  A R Nasution; A Mardjuadi; S Kunmartini; N G Suryadhana; B Setyohadi; D Sudarsono; N M Lardy; T E Feltkamp
Journal:  J Rheumatol       Date:  1997-06       Impact factor: 4.666

5.  HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations.

Authors:  C López-Larrea; K Sujirachato; N K Mehra; P Chiewsilp; D Isarangkura; U Kanga; O Dominguez; E Coto; M Penã; F Setién
Journal:  Tissue Antigens       Date:  1995-03

6.  Induction of alternative splicing of HLA-B27 by bacterial invasion.

Authors:  F Huang; A Yamaguchi; N Tsuchiya; T Ikawa; N Tamura; M M Virtala; K Granfors; P Yasaei; D T Yu
Journal:  Arthritis Rheum       Date:  1997-04

7.  Naturally occurring A pocket polymorphism in HLA-B*2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides.

Authors:  T A Griffin; J Yuan; T Friede; S Stevanovic; K Ariyoshi; S L Rowland-Jones; H G Rammensee; R A Colbert
Journal:  J Immunol       Date:  1997-11-15       Impact factor: 5.422

8.  Invasion by Salmonella typhimurium induces increased expression of the LMP, MECL, and PA28 proteasome genes and changes in the peptide repertoire of HLA-B27.

Authors:  W P Maksymowych; T Ikawa; A Yamaguchi; M Ikeda; D McDonald; L Laouar; R Lahesmaa; N Tamura; A Khuong; D T Yu; K P Kane
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

Review 9.  Arthritis in HLA-B27 transgenic animals.

Authors:  J D Taurog
Journal:  Am J Med Sci       Date:  1998-10       Impact factor: 2.378

10.  The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats.

Authors:  M Zhou; A Sayad; W A Simmons; R C Jones; S D Maika; N Satumtira; M L Dorris; S J Gaskell; R S Bordoli; R B Sartor; C A Slaughter; J A Richardson; R E Hammer; J D Taurog
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

View more
  1 in total

1.  Major histocompatibility complex class I peptide presentation after Salmonella enterica serovar typhimurium infection assessed via stable isotope tagging of the B27-presented peptide repertoire.

Authors:  Jeffrey H Ringrose; Hugo D Meiring; Dave Speijer; Theodorus E W Feltkamp; Cecile A C M van Els; Ad P J M de Jong; Jacob Dankert
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.